SCHEMBL6740529

SCHEMBL6740529

Cc1ccc(-c2cnns2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.41
HPGD P15428 4/20 0.41
GAA P10253 3/20 0.41
MAPT P10636 2/20 0.41
HTT P42858 2/20 0.41
RUNX1 Q01196 2/20 0.41
CBFB Q13951 2/20 0.41
GFER P55789 1/20 0.41
NOTUM Q6P988 2/20 0.39
POLB P06746 1/20 0.39
KMT2A Q03164 1/20 0.39
LMNA P02545 3/20 0.35
METAP2 P50579 1/20 0.35
METAP1 P53582 1/20 0.35
PKM P14618 1/20 0.35
ACHE P22303 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
SMN1; SMN2 Q16637 3/20 0.34
KDM4E B2RXH2 2/20 0.34
ALOX15 P16050 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9134795 0.80 IDO1 (0.42) ALDH1A1HPGDGAAMAPTHTT
SCHEMBL224905 0.78 APP (0.48) ALDH1A1HPGDGAAMAPTHTT
SCHEMBL6740524 0.78 ALDH1A1 (0.41) ALDH1A1HPGDGAAMAPTHTT
SCHEMBL10163319 0.78 METAP2 (0.41) ALDH1A1HPGDGAAMAPTHTT
SCHEMBL10577638 0.78 KIF11 (0.44) ALDH1A1HPGDGAAMAPTHTT
SCHEMBL9136063 0.75 ALDH1A1 (0.51) ALDH1A1HPGDGAAMAPTHTT
SCHEMBL6721322 0.74 ALDH1A1 (0.41) ALDH1A1HPGDGAAMAPTHTT
SCHEMBL6742836 0.74 ALDH1A1 (0.38) ALDH1A1HPGDGAAMAPTHTT
SCHEMBL6721286 0.74 ALDH1A1 (0.38) ALDH1A1HPGDGAAMAPTHTT
SCHEMBL12158655 0.74 ALDH1A1 (0.38) ALDH1A1HPGDGAAMAPTHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7943639-B2 Such as 6-benzenesulfonyl-4-piperazin-1-yl-quinoline hydrochloride; for treatment of central nervous system and/or 5- HT6 receptor related disorders; for weight gain/loss PROXIMAGEN LIMITED (GB) 2011-05-17 US disclosed
US-7943639-B2 Such as 6-benzenesulfonyl-4-piperazin-1-yl-quinoline hydrochloride; for treatment of central nervous system and/or 5- HT6 receptor related disorders; for weight gain/loss PROXIMAGEN LIMITED (GB) 2011-05-17 US disclosed
EP-1897881-A2 Compounds useful for the treatment of obesity, type II diabetes and CNS disorders Biovitrum AB (publ) (SE) 2008-03-12 EP disclosed
US-6689771-B2 TREATMENT OF RHEUMATOID ARTHRITIS, OSTEOARTHRITIS, PERIODONTITIS, GINGIVITIS, CORNEAL ULCERATION, SOLID TUMOR GROWTH BRISTOL-MYERS SQUIBB PHARMA COMPANY 2004-02-10 US disclosed
US-6376665-B1 ANTIARTHRITIC AGENTS, ANTIINFLAMMATORY AGENTS BRISTOL-MYERS SQUIBB PHARMA COMPANY 2002-04-23 US disclosed